---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-138911"
form_type: "8-K"
ticker: "XOMA"
cik: "0000791908"
company_name: "XOMA Royalty Corp"
filed_at: "2023-05-09T23:59:59+00:00"
generated_at: "2026-06-15T10:57:30.429733+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# XOMA Q1 2023 revenue drops to $0.4M; net loss widens to $9.8M; acquires IXINITY stream

## Summary
- Total revenue of $0.4M in Q1 2023 vs $3.1M in Q1 2022; no milestone revenue recognized.
- Net loss of $9.8M ($2.3M loss in Q1 2022) including $4.1M arbitration settlement costs.
- Cash and equivalents $44.3M at March 31, 2023; no debt; operating cash burn $4.9M.
- Acquired IXINITY commercial payment stream from Aptevo in March 2023; payments to begin Q2 2023.
- Received second commercial payment from Roche for Vabysmo (faricimab) in February 2023.

## SEC filing metadata
- accession: 0001193125-23-138911
- form_type: 8-K
- ticker: XOMA
- cik: 0000791908
- company_name: XOMA Royalty Corp
- filed_at: 2023-05-09T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/791908/000119312523138911/0001193125-23-138911-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/791908/000119312523138911/d450885d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-138911
- JSON: https://secwatch.observer/filing/0001193125-23-138911.json
- Plain text: https://secwatch.observer/filing/0001193125-23-138911.txt

## Key facts
- Earnings Releases
  XOMA Royalty Corp reported first quarter of 2023 results: revenue $0.4 million, net income $9.8 million.
  - Period: first quarter of 2023
  - Revenue: $0.4 million
  - Net income: $9.8 million
  - Result: reported results
  source text: XOMA recorded total revenues of $0.4 million for the first quarter of 2023, compared with $3.1 million in the first quarter of 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/791908/000119312523138911/0001193125-23-138911-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.